Consolidated Statement of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Jun. 30, 2020	$ 7,036	$ 15,710,996	$ (16,023,721)	$ (305,689)
Beginning balance, shares at Jun. 30, 2020	7,035,771
Common stock issued to vendors for compensation	$ 21	94,230		94,251
Common stock issued to vendors for compensation, Shares	20,789
Stock option-based board of directors expense		125,605		125,605
Net loss			(3,248,600)	(3,248,600)
Common stock issued for convertible note conversion	$ 332	1,486,728		1,487,060
Common stock issued for convertible note conversion, shares	332,063
Sales of common stock to investors	$ 77	345,933		346,010
Sales of common stock to investors, Shares	76,871
Common stock issued to convertible promissory note holders for prepaid interest	$ 30	147,470		147,500
Common stock issued to convertible promissory note holders for prepaid interest, Shares	29,500
Common stock issued to convertible promissory note holders as additional consideration	$ 43	192,347		192,390
Common stock issued to convertible promissory note holders as additional consideration, Shares	44,250
Stock option-based compensation expense		1,984,075		1,984,075
Ending balance, value at Mar. 31, 2021	$ 7,539	20,087,384	(19,272,321)	822,602
Ending balance shares at Mar. 31, 2021	7,539,244
Beginning balance, value at Dec. 31, 2020	$ 7,114	17,580,272	(18,042,133)	(454,747)
Beginning balance, shares at Dec. 31, 2020	7,114,543
Common stock issued to vendors for compensation	$ 10	43,241		43,251
Common stock issued to vendors for compensation, Shares	9,456
Stock option-based board of directors expense		42,541		42,541
Net loss			(1,230,188)	(1,230,188)
Common stock issued for convertible note conversion	$ 318	1,421,742		1,422,060
Common stock issued for convertible note conversion, shares	317,619
Sales of common stock to investors	$ 24	107,511		107,535
Sales of common stock to investors, Shares	23,876
Common stock issued to convertible promissory note holders for prepaid interest	$ 30	147,470		147,500
Common stock issued to convertible promissory note holders for prepaid interest, Shares	29,500
Common stock issued to convertible promissory note holders as additional consideration	$ 43	192,347		192,390
Common stock issued to convertible promissory note holders as additional consideration, Shares	44,250
Stock option-based compensation expense		552,260		552,260
Ending balance, value at Mar. 31, 2021	$ 7,539	20,087,384	(19,272,321)	822,602
Ending balance shares at Mar. 31, 2021	7,539,244
Beginning balance, value at Jun. 30, 2021	$ 7,580	20,936,050	(22,115,408)	(1,171,778)
Beginning balance, shares at Jun. 30, 2021	7,579,285
Ending balance, value at Dec. 31, 2021	$ 12,480	55,764,735	(25,347,563)	30,429,652
Ending balance shares at Dec. 31, 2021	12,480,416
Beginning balance, value at Jun. 30, 2021	$ 7,580	20,936,050	(22,115,408)	(1,171,778)
Beginning balance, shares at Jun. 30, 2021	7,579,285
Common stock issued for legacy acquisition obligation	$ 453	1,249,547		1,250,000
Common stock issued for legacy acquisition obligation, shares	452,978
Common stock issued to vendors for compensation	$ 15	162,880		162,895
Common stock issued to vendors for compensation, Shares	14,902
Common stock issued for exercise of options	$ 559	1,325,484		$ 1,326,043
Common stock issued for exercise of options, shares	559,775			969,775
Stock based compensation expense	$ 11	1,704,342		$ 1,704,353
Stock based compensation expense, shares	10,841
Stock option-based board of directors expense		332,166		332,166
Net loss			(4,983,768)	(4,983,768)
Common stock issued in Initial Public Offering, net	$ 1,913	11,819,451		11,821,364
Common stock issued in Initial Public Offering, net, shares	1,912,500
Common stock issued in Securities Purchase Agreement, net	$ 1,500	13,576,900		13,578,400
Common stock issued in Securities Purchase Agreement, net, shares	1,500,000
Common stock issued for convertible note conversion	$ 324	1,605,852		1,606,176
Common stock issued for convertible note conversion, shares	324,150
Common stock issued for acquisitions	$ 388	3,346,915		3,347,303
Common stock issued for acquisitions, shares	388,342
Ending balance, value at Mar. 31, 2022	$ 12,743	56,059,587	(27,099,176)	28,973,154
Ending balance shares at Mar. 31, 2022	12,742,773
Beginning balance, value at Dec. 31, 2021	$ 12,480	55,764,735	(25,347,563)	30,429,652
Beginning balance, shares at Dec. 31, 2021	12,480,416
Common stock issued for acquisition - fair value adjustment at close		(1,702,697)		(1,702,697)
Common stock issued for legacy acquisition obligation	$ 58	459,942		460,000
Common stock issued for legacy acquisition obligation, shares	57,978
Common stock issued to vendors for compensation	$ 2	14,998		15,000
Common stock issued to vendors for compensation, Shares	1,529
Common stock issued for exercise of options	$ 203	712,221		712,424
Common stock issued for exercise of options, shares	202,850
Stock based compensation expense		654,090		654,090
Stock option-based board of directors expense		156,298		156,298
Net loss			(1,751,613)	(1,751,613)
Ending balance, value at Mar. 31, 2022	$ 12,743	$ 56,059,587	$ (27,099,176)	$ 28,973,154
Ending balance shares at Mar. 31, 2022	12,742,773